NCT05717400 2024-12-31
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
Phase 4 Terminated
Clinical Trials
4 trialsNCT02959359 2017-08-07
DAA in the Risk of Recurrence After Curative Treatment of HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Withdrawn
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT02771405 2016-05-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Unknown